Pharmaceutical Companies
Reform and incentives
As domestic sales decline, drug makers focus on exports to sustain growth
GMM Pfaudler says ready to respond to charges on unusual trades during OFS
Export boost to help pharma sector come out unscathed from Covid-19: CRISIL
Gilead nears deal to buy Immunomedics for more than $20 billion: Report

Zydus Cadila gets approval from USFDA for muscle relaxant injection
Covid-19 prescription: Pharma players shift their focus over the counter
Firms and lenders provisions for Covid-related losses cross Rs 27,000 cr
Chemist body warns against Amazon's entry into online pharmacy space
Gilead puts $2,340 price tag for coronavirus drug, faces criticism

Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing
Lincoln Pharma gets entry into Europe, will sell derma, gastro drugs
Four in a lift, facing the wall: Office etiquette in Covid-19 times
Surge in demand for preventive drugs seen post lockdown, Ayurveda in focus
Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch
Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports
Shot in the arm: Pharma sales clock double-digit growth in February
'Drugs imported from unregistered dealers cannot be sold to local buyers'
Dr Reddy's to acquire part of Wockhardt's India business for Rs 1,850 crore
Govt may impose anti-dumping duty on a Chinese medicine for infections